Lenvervimab

DB17814InvestigationalProtein Based Therapies

Lenvervimab: Overview.

Mechanism
Curator reviewed
Also known as
Hepabig · Hepatitis B virus neutralizing human monoclonal antibody · Immunoglobulin g1, anti-(hepatitis b surface antigen) (human monoclonal gc1102 .gamma.1-chain), disulfide with human monoclonal gc1102 .kappa.-chain, dimer · Recombinant hepatitis B human immunoglobulin
Code names
GC-1102

Resolves to

Compound
UNIIFX9X4L2A2LCAS2055006-79-4
Targets
Q69600S gene

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Lenvervimab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In